Microphthalmia syndromic 9

From WikiMD's WELLNESSPEDIA

Other Names: MCOPS9; Matthew Wood syndrome; Clinical anophthalmia mild facial dysmorphism lung heart and diaphragm malformations; Anophthalmia/microphthalmia and pulmonary hypoplasia; Spear syndrome; Pulmonary agenesis microphthalmi and diaphragmatic defect

Matthew-Wood syndrome is a rare clinical entity including as main characteristics anophthalmia or severe microphthalmia, and pulmonary hypoplasia or aplasia.

Epidemiology[edit]

Only five cases have been reported so far, two of whom were sibs.

Cause[edit]

The disease are mutations in STRA6 - gene on chromosome 15 locus q24.1 basis.

Inheritance[edit]

Autosomal recessive inheritance, a 25% chance

The frequency is given as less than 1 in 1,000,000, inheritance is autosomal - recessive .

Signs and symptoms[edit]

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed.

80%-99% of people have these symptoms

30%-79% of people have these symptoms

  • Abnormality of cardiovascular system morphology
  • Congenital diaphragmatic hernia
  • Pulmonary hypoplasia(Small lung)

5%-29% of people have these symptoms

  • Abnormal spleen morphology
  • Abnormality of the uterus(Uterine abnormalities)
  • Annular pancreas
  • Aplasia/Hypoplasia of the pancreas(Absent/small pancreas)
  • Cryptorchidism(Undescended testes)
  • Duodenal stenosis(Failure to thrive)
  • Faltering weight
  • Horseshoe kidney(Horseshoe kidneys)
  • Intrauterine growth retardation(Prenatal growth deficiency)
  • Low-set ears(Lowset ears)
  • Muscular hypotonia(Low or weak muscle tone)
  • Renal hypoplasia(Small kidneys)
  • Truncus arteriosus
  • Vesicoureteral reflux

Diagnosis[edit]

Treatment[edit]

NIH genetic and rare disease info[edit]

Microphthalmia syndromic 9 is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.